Smart bomb chemo shows promise against tough lymphoma
NCT ID NCT03113500
First seen Nov 15, 2025 · Last updated Apr 28, 2026 · Updated 22 times
Summary
This study tested a new combination of drugs for people with a rare type of blood cancer called CD30-positive peripheral T-cell lymphoma. The treatment pairs a targeted antibody-drug (brentuximab vedotin) with standard chemotherapy. 48 adults took part to see how well the combo works and what side effects occur. The goal was to shrink or eliminate the cancer after initial treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BCCA-Vancouver Cancer Centre
Vancouver, British Columbia, V5Z 4E6, Canada
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.